Inicio >  Term: dacliximab
dacliximab

A monoclonal antibody that is being studied in the treatment of adult T-cell leukemia and in the treatment of cytopenia (low blood cell count). Also called daclizumab.

0 0

Creador

  • Lionel M
  •  (Platinum) 5532 puntos
  • 100% positive feedback
© 2025 CSOFT International, Ltd.